EdgarLookup

Meritage Homes CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Meritage Homes CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
5.9%
Return on Assets
Net income ÷ assets
0.47x
Debt-to-Equity
Total liabilities ÷ equity

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $171.23M Feb 12, 2018
FY2017 Sep 30, 2017 $144.60M Feb 12, 2018
FY2017 Jun 30, 2017 $140.91M Feb 12, 2018
FY2017 Mar 31, 2017 $109.76M Feb 12, 2018
FY2017 Dec 31, 2016 $157.44M Feb 12, 2018
FY2017 Sep 30, 2016 $131.87M Feb 12, 2018
FY2017 Jun 30, 2016 $138.10M Feb 12, 2018
FY2017 Mar 31, 2016 $103.80M Feb 12, 2018
FY2016 Dec 31, 2015 $152.08M Feb 17, 2017
FY2016 Sep 30, 2015 $126.24M Feb 17, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $453.01M Feb 13, 2026
FY2025 Dec 31, 2024 $786.19M Feb 13, 2026
FY2025 Dec 31, 2023 $738.75M Feb 13, 2026
FY2024 Dec 31, 2022 $992.19M Feb 20, 2025
FY2023 Dec 31, 2021 $737.44M Feb 14, 2024
FY2020 Dec 31, 2020 $152.53M Feb 12, 2021
FY2020 Sep 30, 2020 $109.12M Feb 12, 2021
FY2020 Jun 30, 2020 $90.68M Feb 12, 2021
FY2020 Mar 31, 2020 $71.15M Feb 12, 2021
FY2020 Dec 31, 2019 $103.61M Feb 12, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2014 Dec 31, 2014 $224.52M Feb 17, 2015
FY2014 Dec 31, 2013 $209.41M Feb 17, 2015
FY2014 Dec 31, 2012 $77.80M Feb 17, 2015
FY2013 Dec 31, 2011 $22.94M Feb 19, 2014
FY2012 Dec 31, 2010 $51.54M Feb 22, 2013

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $118.29M Feb 13, 2026
FY2025 Dec 31, 2024 ($227.58M) Feb 13, 2026
FY2025 Dec 31, 2023 $355.57M Feb 13, 2026
FY2024 Dec 31, 2022 $405.27M Feb 20, 2025
FY2023 Dec 31, 2021 ($152.09M) Feb 14, 2024
FY2022 Dec 31, 2020 $530.36M Feb 15, 2023
FY2021 Dec 31, 2019 $346.82M Feb 16, 2022
FY2020 Dec 31, 2018 $262.20M Feb 12, 2021
FY2019 Dec 31, 2017 ($87.13M) Feb 18, 2020
FY2018 Dec 31, 2016 ($103.40M) Feb 15, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $25.72M Feb 13, 2026
FY2025 Dec 31, 2024 $28.66M Feb 13, 2026
FY2025 Dec 31, 2023 $38.19M Feb 13, 2026
FY2024 Dec 31, 2022 $26.97M Feb 20, 2025
FY2023 Dec 31, 2021 $25.66M Feb 14, 2024
FY2022 Dec 31, 2020 $19.93M Feb 15, 2023
FY2021 Dec 31, 2019 $24.39M Feb 16, 2022
FY2020 Dec 31, 2018 $33.42M Feb 12, 2021
FY2019 Dec 31, 2017 $18.10M Feb 18, 2020
FY2018 Dec 31, 2016 $16.66M Feb 15, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.62B Feb 13, 2026
FY2025 Dec 31, 2024 $7.16B Feb 13, 2026
FY2024 Dec 31, 2023 $6.35B Feb 20, 2025
FY2023 Dec 31, 2022 $5.77B Feb 14, 2024
FY2022 Dec 31, 2021 $4.81B Feb 15, 2023
FY2021 Dec 31, 2020 $3.86B Feb 16, 2022
FY2020 Dec 31, 2019 $3.40B Feb 12, 2021
FY2019 Dec 31, 2018 $3.37B Feb 18, 2020
FY2018 Dec 31, 2017 $3.25B Feb 15, 2019
FY2017 Dec 31, 2016 $2.89B Feb 12, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.43B Feb 13, 2026
FY2025 Dec 31, 2024 $2.02B Feb 13, 2026
FY2024 Dec 31, 2023 $1.74B Feb 20, 2025
FY2023 Dec 31, 2022 $1.82B Feb 14, 2024
FY2022 Dec 31, 2021 $1.76B Feb 15, 2023
FY2021 Dec 31, 2020 $1.52B Feb 16, 2022
FY2020 Dec 31, 2019 $1.42B Feb 12, 2021
FY2019 Dec 31, 2018 $1.64B Feb 18, 2020
FY2018 Dec 31, 2017 $1.67B Feb 15, 2019
FY2017 Dec 31, 2016 $1.47B Feb 12, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.20B Feb 13, 2026
FY2025 Dec 31, 2024 $5.14B Feb 13, 2026
FY2025 Dec 31, 2023 $4.61B Feb 13, 2026
FY2025 Dec 31, 2022 $3.95B Feb 13, 2026
FY2024 Dec 31, 2021 $3.04B Feb 20, 2025
FY2023 Dec 31, 2020 $2.35B Feb 14, 2024
FY2022 Dec 31, 2019 $1.97B Feb 15, 2023
FY2021 Dec 31, 2018 $1.72B Feb 16, 2022
FY2020 Dec 31, 2017 $1.58B Feb 12, 2021
FY2019 Dec 31, 2016 $1.42B Feb 18, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $32.96M Feb 13, 2026
FY2025 Dec 31, 2024 $32.96M Feb 13, 2026
FY2025 Dec 31, 2023 $32.96M Feb 13, 2026
FY2024 Dec 31, 2022 $32.96M Feb 20, 2025
FY2023 Dec 31, 2021 $32.96M Feb 14, 2024
FY2022 Dec 31, 2020 $32.96M Feb 15, 2023
FY2021 Dec 31, 2019 $32.96M Feb 16, 2022
FY2020 Dec 31, 2018 $32.96M Feb 12, 2021
FY2019 Dec 31, 2017 $32.96M Feb 18, 2020
FY2018 Dec 31, 2016 $32.96M Feb 15, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.19B Feb 13, 2026
FY2025 Dec 31, 2024 $5.00B Feb 13, 2026
FY2024 Dec 31, 2023 $4.32B Feb 20, 2025
FY2023 Dec 31, 2022 $3.62B Feb 14, 2024
FY2022 Dec 31, 2021 $2.63B Feb 15, 2023
FY2021 Dec 31, 2020 $1.89B Feb 16, 2022
FY2020 Dec 31, 2019 $1.47B Feb 12, 2021
FY2019 Dec 31, 2018 $1.22B Feb 18, 2020
FY2018 Dec 31, 2017 $991.84M Feb 15, 2019
FY2017 Dec 31, 2016 $848.59M Feb 12, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $775.16M Feb 13, 2026
FY2025 Dec 31, 2024 $651.56M Feb 13, 2026
FY2024 Dec 31, 2023 $921.23M Feb 20, 2025
FY2023 Dec 31, 2022 $861.56M Feb 14, 2024
FY2022 Dec 31, 2021 $618.34M Feb 15, 2023
FY2021 Dec 31, 2020 $745.62M Feb 16, 2022
FY2020 Dec 31, 2019 $319.47M Feb 12, 2021
FY2019 Dec 31, 2018 $311.47M Feb 18, 2020
FY2018 Dec 31, 2017 $170.75M Feb 15, 2019
FY2018 Dec 31, 2016 $131.70M Feb 15, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 $905.06M Feb 19, 2014
FY2012 Dec 31, 2012 $726.33M Feb 22, 2013

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 13, 2026
FY2025 Dec 31, 2024 10 Feb 13, 2026
FY2025 Dec 31, 2023 10 Feb 13, 2026
FY2024 Dec 31, 2022 13 Feb 20, 2025
FY2023 Dec 31, 2021 19 Feb 14, 2024
FY2020 Dec 31, 2020 4 Feb 12, 2021
FY2020 Sep 30, 2020 2 Feb 12, 2021
FY2020 Jun 30, 2020 2 Feb 12, 2021
FY2020 Mar 31, 2020 1 Feb 12, 2021
FY2020 Dec 31, 2019 2 Feb 12, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 13, 2026
FY2025 Dec 31, 2024 10 Feb 13, 2026
FY2025 Dec 31, 2023 9 Feb 13, 2026
FY2024 Dec 31, 2022 13 Feb 20, 2025
FY2023 Dec 31, 2021 19 Feb 14, 2024
FY2020 Dec 31, 2020 3 Feb 12, 2021
FY2020 Sep 30, 2020 2 Feb 12, 2021
FY2020 Jun 30, 2020 2 Feb 12, 2021
FY2020 Mar 31, 2020 1 Feb 12, 2021
FY2020 Dec 31, 2019 2 Feb 12, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 68.17M Feb 13, 2026
FY2025 Dec 31, 2024 71.92M Feb 13, 2026
FY2024 Dec 31, 2023 72.85M Feb 20, 2025
FY2023 Dec 31, 2022 36.57M Feb 14, 2024
FY2022 Dec 31, 2021 37.34M Feb 15, 2023
FY2021 Dec 31, 2020 37.51M Feb 16, 2022
FY2020 Dec 31, 2019 38.20M Feb 12, 2021
FY2019 Dec 31, 2018 38.07M Feb 18, 2020